Open AccessImpact of the presence of heart disease, cardiovascular medications and cardiac events on outcome in COVID-19
Author(s) -
Gonzalo Cabezón Villalba,
Ignacio J. AmatSantos,
Carlos Dueñas,
Diego López Otero,
Pablo Catalá,
Álvaro Alonso,
Javier López-País,
Carla Cacho-Antonio,
Jordi Candela,
Pablo Antúnez Muiños,
José Francisco López Gil,
T Gonzalez Ferrero,
Marta Marcos,
Marta Pérez-Poza,
Gino Rojas,
O. Otero García,
Carlos Veras,
Vítor Ramos,
Aitor Uribarri,
Ana Revilla,
Pablo Elpidio GarcíaGranja,
Itzíar Gómez,
José Ramón González-Juanatey,
José Alberto San Román
Publication year - 2021
Publication title -
cardiology journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.573
H-Index - 33
eISSN - 1897-5593
pISSN - 1898-018X
DOI - 10.5603/cj.a2021.0034
Subject(s) - medicine , hazard ratio , diabetes mellitus , heart failure , disease , cardiology , population , retrospective cohort study , multivariate analysis , proportional hazards model , confidence interval , environmental health , endocrinology
Cardiovascular risk factors and usage of cardiovascular medication are prevalent among coronavirus disease 2019 (COVID-19) patients. Little is known about the cardiovascular implications of COVID-19. The goal herein, was to evaluate the prognostic impact of having heart disease (HD) and taking cardiovascular medications in a population diagnosed of COVID-19 who required hospitalization. Also, we studied the development of cardiovascular events during hospitalization.